[1]
|
Castagnola, E., Rossi, M.R., Cesaro, S., et al. (2010) Incidence of Bacteremias and Invasive Mycoses in Children with Acute Non-Lymphoblastic Leukemia: Results from a Multi-Center Italian Study. Pediatric Blood & Cancer, 55, 1103-1107.
https://doi.org/10.1002/pbc.22750
|
[2]
|
肖秀红, 徐凤琴, 卢妤, 等. 儿科血液病患儿医院血流感染分析[J]. 中外医学研究, 2016,14(25): 125-126+127.
https://doi.org/10.14033/j.cnki.cfmr.2016.25.067
|
[3]
|
陈琳, 王津雨, 李睿, 等. 血液病住院患者3年医院感染现患率调查[J]. 中国感染控制杂志, 2017, 16(4): 369-371.
https://doi.org/10.3969/j.issn.1671-9638.2017.04.020
|
[4]
|
杜香洲, 杨红, 廖金. 血液病患者医院获得性肺炎临床分析[J]. 中华医院感染学杂志, 2011, 21(2): 254-255.
|
[5]
|
中华儿科杂志编辑委员会, 中华医学会儿科学分会呼吸学组, 中华医学会儿科学分会急救学组, 等. 儿童医院获得性肺炎管理方案(2010版) [J]. 中华儿科杂志, 2011, 49(2): 106-115.
https://doi.org/10.3760/cma.j.issn.0578-1310.2011.02.008
|
[6]
|
中华医学会. [指南]抗菌药物临床应用指导原则(2004版) [J]. 中华医学会, 2015, 7(9): 118-124.
|
[7]
|
姚佳峰, 蔡思雨, 李楠, 等. 2016-2017年单中心血液肿瘤患儿感染病原菌分布的临床特点分析[J]. 北京医学, 2018, 40(4): 301-304. https://doi.org/10.15932/j.0253-9713.2018.04.004
|
[8]
|
Garrido, M.M., Garrido, R.Q., Cunha, T.N., et al. (2019) Comparison of Epidemiological, Clinical and Microbiological Characteristics of Bloodstream Infection in Children with Solid Tumours and Haematological Malignancies. Epidemiol Infect, 147, e298. https://doi.org/10.1017/S0950268819001845
|
[9]
|
Liu, H., Zhao, J., Xing, Y., et al. (2014) Nosocomial Infection in Adult Admissions with Hematological Malignancies Originating from Different Lineages: A Prospective Observational Study. PLoS ONE, 9, e113506.
https://doi.org/10.1371/journal.pone.0113506
|
[10]
|
Tatarelli, P. and Mikulska, M. (2016) Multidrug-Resistant Bacteria in Hematology Patients: Emerging Threats. Future Microbiology, 11, 767-780. https://doi.org/10.2217/fmb-2015-0014
|
[11]
|
The, B.W., Harrison, S.J., Slavin, M.A., et al. (2017) Epidemiology of Bloodstream Infections in Patients with Myeloma Receiving Current Era Therapy. European Journal of Haematology, 98, 149-153.
https://doi.org/10.1111/ejh.12813
|
[12]
|
Chen, C.Y., Tien, F.M., Sheng, W.H., et al. (2017) Clinical and Microbiological Characteristics of Bloodstream Infections among Patients with Haematological Malignancies with and without Neutropenia at a Medical Centre in northern Taiwan, 2008-2013. International Journal of Antimicrobial Agents, 49, 272-281.
https://doi.org/10.1016/j.ijantimicag.2016.11.009
|
[13]
|
田磊, 王继军, 景红梅, 等. 恶性血液病患者合并血流感染的临床和病原学特征[J]. 中国感染与化疗杂志, 2017,17(5): 504-508.
|
[14]
|
中华医学会血液学分会, 中国医师协会血液科医师分会. 中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2016年版) [J]. 中华血液学杂志, 2016, 37(5): 353-359.
|
[15]
|
Liu, W.D., Shih, M.C., Chuang, Y.C., et al. (2019) Comparative Efficacy of Doripenem versus Meropenem for Hospital-Acquired and Ventilator-Associated Pneumonia. Journal of Microbiology, Immunology and Infection, 52, 788-795.
https://doi.org/10.1016/j.jmii.2019.04.008
|
[16]
|
Surveillance, C. (2020) Healthcare-Associated Infections and Antimicrobial Resistance in Canadian Acute Care Hospitals, 2014-2018. Canada Communicable Disease Report, 46, 99-112.
https://doi.org/10.14745/ccdr.v46i05a01
|
[17]
|
吴方强, 许夕海. 2014~2018年我院耐碳青霉烯类肺炎克雷伯菌分布特点及感染患者的临床特点[J]. 医学信息, 2019, 32(24): 28-31. https://doi.org/10.3969/j.issn.1006-1959.2019.24.010
|
[18]
|
张国扬, 吴裕丹, 谢双锋, 等. 2012-2016年血液病患者血流感染病原菌分布及耐药性[J]. 中国感染控制杂志, 2018, 17(10): 853-859.
|
[19]
|
Huang, Y., Jiao, Y., Zhang, J., et al. (2018) Microbial Etiology and Prognostic Factors of Ventilator-Associated Pneumonia: A Multicenter Retrospective Study in Shanghai. Clinical Infectious Diseases, 67, S146-S152.
https://doi.org/10.1093/cid/ciy686
|
[20]
|
Thabit, A.K., Crandon, J.L. and Nicolau, D.P. (2015) Antimicrobial Resistance: Impact on Clinical and Economic Outcomes and the Need for New Antimicrobials. Expert Opinion on Pharmacotherapy, 16, 159-177.
https://doi.org/10.1517/14656566.2015.993381
|
[21]
|
Blennow, O. and Ljungman, P. (2016) The Challenge of Antibiotic Resistance in Haematology Patients. British Journal of Haematology, 172, 497-511. https://doi.org/10.1111/bjh.13816
|
[22]
|
Carvalhaes, C.G., Shortridge, D., Sader, H.S. and Castanheira, M. (2020) Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018. Antimicrob Agents Chemother, 64, e02177-19. https://doi.org/10.1128/AAC.02177-19
|
[23]
|
Meletis, G. (2016) Carbapenem Resistance: Overview of the Problem and Future Perspectives. Therapeutic Advances in Infectious Disease, 3, 15-21. https://doi.org/10.1177/2049936115621709
|
[24]
|
Hu, F., Guo, Y., Yang ,Y., et al. (2019) Resistance Reported from China Antimicrobial Surveillance Network (CHINET) in 2018. European Journal of Clinical Microbiology & Infectious Diseases, 38, 2275-2281.
https://doi.org/10.1007/s10096-019-03673-1
|
[25]
|
Hu, F.P., Guo, Y., Zhu, D.M., et al. (2016) Resistance Trends among Clinical Isolates in China Reported from CHINET Surveillance of Bacterial Resistance, 2005-2014. Clinical Microbiology and Infection, 22, S9-S14.
https://doi.org/10.1016/j.cmi.2016.01.001
|
[26]
|
庄婧, 韦杰敏, 刘倍材, 等. 血液病患者粒细胞缺乏期革兰阴性菌血流感染的病原菌分布及药敏特点[J]. 广西医学, 2019, 41(23): 3023-3025+3032.
|
[27]
|
苗文娟, 林青松, 章萍. 血液病患者碳青霉烯类抗菌药物使用强度与病原菌耐药率的相关性分析[J]. 中国医药指南, 2018, 16(18): 153-154.
|
[28]
|
宋晓超, 杨海飞, 陈凯, 等. 2013-2018年恶性血液病患者血流感染病原菌与耐药性变迁[J]. 中华医院感染学杂志, 2018, 28(11): 1641-1644+1692. https://doi.org/10.11816/cn.ni.2018-180941
|
[29]
|
Weiner, L.M., Webb, A.K., Limbago, B., et al. (2016) Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infection Control & Hospital Epidemiology, 37, 1288-1301.
https://doi.org/10.1017/ice.2016.174
|
[30]
|
Gavriliu, L.C., Benea, O.E. and Benea, S. (2016) Antimicrobial Resistance Temporal Trend of Klebsiella pneumoniae Isolated from Blood. Journal of Medicine and Life, 9, 419-423.
|
[31]
|
Kolonen, A., Sinisalo, M., Huttunen, R., et al. (2017) Bloodstream Infections in Acute Myeloid Leukemia Patients treated According to the Finnish Leukemia Group AML-2003 Protocol—A Prospective Nationwide Study. Infectious Diseases, 49, 799-808. https://doi.org/10.1080/23744235.2017.1347814
|
[32]
|
Trivedi, M., Patel, V., Soman, R., et al. (2012) The Outcome of Treating ESBL Infections with Carbapenems vs. Non Carbapenem Antimicrobials. Journal of the Association of Physicians of India, 60, 28-30.
|
[33]
|
Tamura, K., Akiyama, N., Kanda, Y., et al. (2015) Efficacy and Safety of Tazobactam/Piperacillin as an Empirical Treatment for the Patients of adult and Child with Febrile Neutropenia in Japan. Journal of Infection and Chemotherapy, 21, 654-662. https://doi.org/10.1016/j.jiac.2015.05.009
|